Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-09-27 00:00:00 ET · period of report 2021-09-23 · accession 0001219036-21-000029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-27 | 2021-09-23 | MYGN | LANCHBURY JERRY S | CSO | S - Sale | $35.06 | -200 | 288.5K | -0.1% | -$7,012 | |
| M | 2021-09-27 | 2021-09-25+ | MYGN | LANCHBURY JERRY S | CSO | F - Tax | $33.31 | -13.4K | 278.8K | -5% | -$445.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-23 | S | D | 200 | $35.06 | 288,515 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-26 | F | D | 3,633 | $33.31 | 275,135 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-25 | F | D | 9,747 | $33.31 | 278,768 | D | — | — |